Drug Shortage Report for GLYCOPYRROLATE INJECTION USP

Last updated on 2022-11-29 History
Report ID 169242
Drug Identification Number 02473879
Brand name GLYCOPYRROLATE INJECTION USP
Common or Proper name GLYCOPYRROLATE INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) GLYCOPYRROLATE
Strength(s) 0.2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging size 10 VIALS 1 ML
ATC code A03AB
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-09-22
Actual start date
Estimated end date 2022-12-30
Actual end date
Shortage status Actual shortage
Updated date 2022-11-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-09-14 English Compare
v2 2022-09-14 French Compare
v3 2022-09-23 English Compare
v4 2022-11-03 English Compare
v5 2022-11-03 French Compare
v6 2022-11-29 English Compare
v7 2022-11-29 English Compare
v8 2022-11-29 French Compare

Showing 1 to 8 of 8